Back
Protagonist Therapeutics Vs. CVS Health Industry Stock Comparison
Buy
63
PTGX
Protagonist Therapeutics
Last Price:
32.48
Seasonality Move:
4.6%
Sell
49
CVS
CVS Health
Last Price:
61.09
Seasonality Move:
1.72%
Buy
63
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $32.47. The Score for PTGX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
CVS Health (CVS)
is a Sell
Is CVS Health a Buy, Sell or Hold?
- The current CVS Health [CVS] share price is $61.09. The Score for CVS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $32.47
The current trend is moderately bullish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
CVS Stock Price Chart
What is CVS Health's stock price today?
-
The CVS Health share price today is $61.09
The current trend is relatively stagnant and CVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.35 | Buy |
| Relative Strength Index (14 RSI): | 55.49 | Buy |
| Chaikin Money Flow: | -537205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.32 - 33.54) | Buy |
| Bollinger Bands (100): | (26.08 - 31.1) | Buy |
CVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 55.18 | Buy |
| Chaikin Money Flow: | 5971555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.89 - 60.65) | Buy |
| Bollinger Bands (100): | (60.34 - 77.12) | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.77 | Sell |
| 20-day SMA: | 31.63 | Buy |
| 50-day SMA: | 28.94 | Buy |
| 200-day SMA: | 23.65 | Buy |
| 8-day EMA: | 33.1 | Sell |
| 20-day EMA: | 31.84 | Buy |
| 50-day EMA: | 29.97 | Buy |
| 200-day EMA: | 25.49 | Buy |
CVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.67 | Buy |
| 20-day SMA: | 58.64 | Buy |
| 50-day SMA: | 61.62 | Sell |
| 200-day SMA: | 70.28 | Sell |
| 8-day EMA: | 60.37 | Buy |
| 20-day EMA: | 59.67 | Buy |
| 50-day EMA: | 62.16 | Sell |
| 200-day EMA: | 69.63 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
CVS Health Earnings Growth & CVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.07 per share, a decrease this year of $1.57 per share, and an increase next year of $0.98 per share.
Protagonist Therapeutics Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CVS Health Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||